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Objectives. The purpose of this study was to investigate whether
or not there is an association between managed care insurance
and the delivery and outcome of care in patients presenting with
unstable angina.
Background. The proportion of U.S. patients with managed
care health insurance is increasing. This may be associated with
recent improvements in the control of health care costs. It is
unknown whether or not there is a difference in process of care in
angina patients presenting with managed care versus fee-for-
service health insurance.
Methods. We compared baseline characteristics, process and
outcome of care in 636 patients with managed care insurance
(MC) and 1,404 patients with fee-for-service (FFS) insurance who
presented with unstable angina to 35 hospitals participating in
the global Unstable Angina Registry and Treatment Evaluation
(GUARANTEE) Registry.
Results. Although, there was little difference in baseline char-
acteristics and hospital treatments between cohorts, MC patients
were more likely to be discharged on guideline-recommended
medications (aspirin and beta-adrenergic blocking agents). In
addition, FFS patients were more likely to undergo cardiac
catheterization (odds ratio 5 1.25 95% confidence interval 5 1.1
to 1.5), but not revascularization during the hospitalization. There
was no difference in hospital mortality (0.9% versus 1.2% in MC
versus FFS; p 5 0.60).
Conclusions. In patients admitted with suspected unstable
angina, MC patients are less likely to undergo coronary angiog-
raphy, but are more likely to be discharged on indicated medica-
tions.
(J Am Coll Cardiol 1998;32:387–92)
©1998 by the American College of Cardiology
The rate of growth of United States (U.S.) medical expendi-
tures has decreased in the past several years as a result of, in
part, the growth of managed care plans (1–3). Although there
are differences in the organizational detail of these plans, as a
whole, managed care plans attempt to control resource utili-
zation through administrative efforts that encourage preven-
tive services and discourage the use of specialists and proce-
dures (4). These mechanisms include the use of primary care
or “gatekeepers” to control access to specialists, the use of
capitation, as well as the use of salaried physicians to eliminate
financial incentives to perform procedures.
Previous studies that compared resource utilization in
patients in fee-for-service versus managed care systems have
shown that lower costs attributed to managed care were a
result of decreased admission among enrollees, as well as
shorter hospital stays for specific conditions (4–6). In patients
with acute myocardial infarction (AMI), those admitted to
staff-model health maintenance organization hospitals were
less likely to undergo invasive cardiac procedures than patients
admitted to fee-for-service hospitals (7). Although no major
differences in hospital mortality have been reported, there
remains a concern that the cost reduction strategies used by
managed care organizations could result in reduced quality of
care in hospitalized patients (8,9).
For patients admitted with the presumed diagnosis of
unstable angina, there is more diagnostic uncertainty that
those patients with AMI (10,11). In addition, there is probably
more variation in care in these patients as fewer therapies have
proven efficacy in this population of patients (12). To evaluate
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whether or not insurance status is associated with differences in
process or outcome of care in unstable angina patients, we
analyzed insurance status in a large national registry of patients
admitted with chest pain and the presumed diagnosis of
unstable angina.
Methods
Patients. The subjects of this study were 2,948 patients
admitted to 1 of 35 hospitals participating in the Global
Unstable Angina Registry and Treatment Evaluation (GUAR-
ANTEE). The GUARANTEE Registry was an investigator-
initiated study that attempted to document current treatment
and outcome in a cross-sectional sample of unstable angina
patients admitted to a wide variety of U.S. hospitals. Consec-
utive patients with the admission diagnosis consistent with
unstable angina were included in the Registry. In addition to
the admission diagnosis of unstable angina, Registry patients
also included those with the admission diagnosis of coronary
artery disease, acute coronary syndromes, “rule-out myocardial
infarction” or chest pain. Exclusion criteria included AMI with
ST-segment elevation, admission for a planned coronary re-
vascularization procedure or noncardiac chest pain. To main-
tain geographic balance, no more than 200 patients from each
participating medical center could be included in the registry
(mean enrollment per site 84 6 39 patients). Dates of enroll-
ment were from September 1995 through August 1996. Eighty-
six percent of GUARANTEE Registry hospitals had on-site
cardiac catheterization facilities and 72% had on-site coronary
bypass surgery facilities.
To investigate the association between insurance status and
process and outcome of care we divided the Registry into
patients with fee-for-service (FFS) or managed care (MC)
insurance. Insurance status was obtained from chart review
and collected from the primary payor information on the
demographic sheet. For patients with supplemental insurance
coverage, only the primary payor was used for insurance
classification. Fee-for-service patients included those with FFS
indemnity insurance (16%) as well as FFS Medicare (23%).
The managed care group included MC patients as well as
Medicare MC (2%). Specific details of the MC insurance (e.g.,
staff model) were not collected. Self-pay (11%) and Medicaid
patients (11%) were excluded from the analysis. Additional
analyses were performed after excluding Medicare patients
from the FFS cohort.
Data collected. Research coordinators at each site com-
pleted the three-page case report form. Data were collected on
basic demographic information, admitting physician specialty,
past medical history, hospital presentation, medication use on
admission and at discharge, invasive and noninvasive proce-
dure use, as well as hospital complications and outcome. ICD-9
discharge diagnoses were also collected.
Statistical methods. We used chi-square and Student’s t
tests to test for differences in baseline characteristics between
patients with FFS versus MC insurance. Comparison of length-
of-stay was made using the Mann-Whitney two-sample test
(13). “Appropriate catheterization” was based on the Agency
for Health Care Policy and Research (AHCPR) guidelines for
the diagnosis and management of unstable angina (14). To test
whether FFS patients were more likely to undergo cardiac
catheterization or coronary revascularization (defined as the
use of coronary angioplasty or bypass surgery during the index
hospitalization), we constructed a series of logistic regression
models. Variables that were significantly associated with car-
diac catheterization in univariate comparisons (p , 0.10), as
well as those variables we considered clinically relevant, en-
tered the multivariate model in a stepwise fashion, with
insurance type (MC versus FFS) forced into the model at the
final step. These variables included age, gender, race, admis-
sion electrocardiogram (ECG), smoking status, history of
angina, myocardial infarction, heart failure, stroke, diabetes,
angioplasty or bypass surgery as well as “ruling in” for myo-
cardial infarction during the hospital stay. Similar models were
developed for the use of appropriate catheterization (as de-
fined by AHCPR guidelines) as well as revascularization with
the same variables entering the mode. The multivariate asso-
ciation between insurance type and the use of beta-adrenergic
blocking agents as well as the use of aspirin on discharge used
the same set of adjustment variables with the addition of a
history of peptic ulcer disease as well as the use of coronary
angioplasty or bypass surgery during the hospital stay.
To evaluate whether length-of-stay in MC patients was
different than FFS hospitals, we used a linear regression model
to calculate length-of-stay after adjusting for differences be-
tween cohorts. Variables contained in this model included age,
gender, race, admission ECG, history of angina, myocardial
infarction, heart failure, stroke, diabetes, angioplasty or bypass
surgery, “ruling in” for myocardial infarction during the hos-
pital stay, as well as the use of coronary angioplasty or bypass
surgery. Because the distribution of length-of-stay was not
normal, we used the logarithmic transformation of length of
stay as the dependent variable in this model.
Because a large proportion of FFS patients had Medicare
insurance, a separate analysis was performed after excluding
patients with Medicare insurance. Univariate and multivariate
comparisons as described above were performed in this sub-
group of patients.
Abbreviations and Acronyms
AHCPR 5 agency for health care policy and research
AMI 5 acute myocardial infarction
ECG 5 electrocardiogram
FFS 5 fee-for-service
GUARANTEE 5 global unstable angina registry and
treatment evaluation registry
MITI 5 myocardial infarction triage and
intervention
MC 5 managed care insurance
U.S. 5 United States
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Results
Baseline characteristics. A total of 2,948 patients were
included in the Registry. The mean age of the cohort was 62 6
13 years and 61% were male. In this group of patients admitted
with presumed unstable angina, 11% eventually were diag-
nosed with a myocardial infarction and 32% were eventually
diagnosed with noncardiac chest pain.
In the primary comparison there were 636 patients with MC
insurance and 1,404 patients with FFS insurance. Overall, the
proportion of MC patients admitted to the 31 participating
hospitals was 31.2% (range 0% to 85%). On the basis of the
four census regions, MC insurance was most common in the
western United States (west 42.0%, northeast 35.1%, midwest
27.1%, and south 11.4%). Fee-for-service patients were older
(66.8 6 13.0 versus 61.1 6 12.9 p 5 0.001), more likely to be
women, and more likely to be white race than MC patients
(Table 1). Past medical histories were similar, although FFS
patients were less likely to be diabetic or current smokers and
more likely to have had previous heart failure.
Process of care. Process of care after hospital presentation
was similar in patients with FFS versus MC insurance (Table
2). The majority of patients were under the primary care of a
cardiologist with FFS patients less likely to be cared for by a
cardiologist (69% versus 74% p 5 0.001 for FFS and MC
patients, respectively). Fee-for-service patients were less likely
to be admitted to the coronary care unit (37% versus 46% p 5
0.001).
During the hospitalization, FFS patients were less likely to
be treated with beta-blockers (54% versus 60% p 5 0.009), but
there was no difference in the use of heparin (66% versus 68%
p 5 0.336) or aspirin (87% versus 86% p 5 0.67). Fee-for-
service patients were less likely to be discharged on aspirin,
beta-blockers, nitrates or calcium channel blockers (Fig. 1).
After multivariate adjustment, FFS patients were less likely to
be discharged with either aspirin (odds ratio 5 0.74; 95%
confidence interval 5 0.60 to 0.92) or beta-blockers (odds
ratio 5 0.79; 95% CI 5 0.66 to 0.97).
There was no difference in the use of exercise treadmill
testing (15% versus 17% p 5 0.236 for FFS and MC, respec-
tively), coronary angiography (51% versus 48% p 5 0.2) or
coronary interventions (17% versus 19% p 5 0.242) (Table 2).
There was no difference in the proportion of patients who
underwent appropriate coronary angiography according to the
AHCPR guidelines (73% versus 73% p 5 0.82). There was no
association between insurance type and the use of appropriate
coronary angiography after multivariate adjustment (odds ra-
tio 5 0.92 95% CI 5 0.63 to 1.3). Fee-for-service patients were
more likely to undergo bypass surgery (10.0% versus 6.6% p 5
0.013). Length of hospital stay was 0.6 days longer in FFS
patients (4.3 6 4.4 versus 3.7 6 3.5 days; p 5 0.008). There was
no difference in length of hospital stay between cohorts after
multivariate adjustment (beta 5 0.007; p 5 0.71).
To evaluate the association between insurance type and the
use of invasive cardiac procedures independent of differences
in baseline characteristics, we performed a series of logistic
regression models. Factors that were associated with a greater
likelihood of undergoing cardiac catheterization included
white race, younger age, previous use of angioplasty, previous
angina, abnormal admission electrocardiogram, as well as
Figure 1. Discharge medications in 2,948 unstable angina patients in
the GUARANTEE Registry. The proportion of managed care versus
fee-for-service patients discharged on aspirin, beta-blockers, nitrates
and calcium channel blockers. Managed care patients were more likely
to be discharged on guideline recommended medications.
Table 1. Baseline Characteristics in Patients With Fee-for-Service
Versus Managed Care Insurance
Managed Care
(n 5 636)
Fee-for-Service
(n 5 1,404) p Value
Age (mean 6 SD) 61.1 6 12.9 66.8 6 13 0.001
Female gender (%) 30 45 0.001
White (%) 80 84 0.033
Prior diabetes (%) 30 25 0.012
Prior infarct (%) 37 36 0.686
Prior heart failure (%) 12 17 0.005
Prior PTCA (%) 27 23 0.049
Prior bypass (%) 22 22 0.917
Current smoker (%) 26 19 0.001
ST changes on ECG (%) 27 35 0.001
PTCA 5 percutaneous transluminal coronary angioplasty.
Table 2. Process of Care Measures in Patients With Fee-for-Service
Versus Managed Care Insurance
Managed
Care
(n 5 636)
Fee-for-Service
(n 5 1,404) p Value
Initially seen by ER physician (%) 78 77 0.055
Initially seen by cardiologist (%) 12 13 0.055
Cared for by cardiologist (%) 74 69 0.001
Initial admission: ICU/CCU (%) 46 37 0.001
Exercise treadmill testing (%) 17 15 0.236
Coronary angiography (%) 48 51 0.202
Coronary intervention (%) 19 17 0.242
Bypass surgery (%) 7 10 0.013
Length-of-stay (mean 6 SD) 3.7 6 3.5 4.3 6 4.4 0.008
ER 5 emergency room; ICU/CCU 5 intensive care unit/coronary care unit.
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ruling-in for a myocardial infarction during the hospitalization
(Fig. 2). Factors associated with a lower likelihood of under-
going catheterization included female gender and previous
myocardial infarction, stroke or heart failure. After adjusting
for these factors, FFS patients were more likely than MC
patients to undergo cardiac catheterization (odds ratio 5 1.25;
95% CI 5 1.1 to 1.5). For patients who underwent cardiac
catheterization, there was no association between insurance
status and the use of revascularization (odds ratio 5 1.0; 95%
CI 5 0.75 to 1.4).
In-hospital outcomes were similar between cohorts. Al-
though FFS patients were more likely to develop a myocardial
infarction within 16 h of admission, there were no differences
in the proportion of patients who had recurrent myocardial
infarction or who developed recurrent chest pain or stroke
(Table 3). There was no difference in hospital mortality (1.2%
versus 0.9% in FFS versus MC; p 5 0.595).
Non-Medicare fee-for-service subgroup. Because the anal-
ysis may have been confounded by including Medicare patients
in the FFS cohort, we repeated the comparison but included
only those with non-Medicare indemnity insurance in the FFS
cohort. In this comparison there were 623 MC patients and 807
FFS patients. After excluding Medicare patients, the FFS
patients were still slightly older than MC patients (62.9 versus
61.0; p 5 0.006), more likely to be women and white. Fee-for-
service patients were less likely to have had a previous infarct
(32% versus 37%; p 5 0.05), other univariate comparisons
were similar to the principal analysis.
Process of care findings in this group of patients was also
similar to the principal analysis. Fee-for-service patients were
less likely to be discharged on aspirin (65% versus 75%; p ,
0.001), beta-blockers (36% versus 47%; p , 0.001) as well as
calcium channel blockers (30% versus 38%; p 5 0.001). There
was no difference in the use of invasive cardiac procedures
(coronary angiography 51% versus 48% p 5 0.379; coronary
intervention 17% versus 19%; p 5 0.359 or bypass surgery 8%
versus 7%; p 5 0.225 in FFS versus MC, respectively). After
multivariate adjustment, however, FFS patients were more
likely to undergo coronary angiography (odds ratio 5 1.3; 95%
CI 5 1.04 to 1.64), but there was no difference in the use of
revascularization (odds ratio 5 1.1; 95% CI 5 0.85 to 1.4).
There were few hospital deaths and there was no difference in
hospital mortality as a function of insurance status (hospital
mortality, 1.0% versus 0.9%; p 5 0.925 for FFS and MC,
respectively).
Discussion
There has been substantial growth in market share of
managed care insurance in the U.S. health care market (2,15).
Although this growth is probably associated with better control
of rising health care costs, concern has been raised about
whether quality of care can be preserved in the managed care
environment (2,3,8,9). For patients admitted with acute coro-
nary syndromes, there is substantial variation in process of care
(12). This may be particularly true in patients with unstable
angina, as there are fewer treatments available with proven
efficacy (16–23). Recently published guidelines for the treat-
ment of unstable angina have highlighted the use of aspirin,
heparin, beta-blockers and invasive evaluation for appropriate
patients (14). We evaluated whether or not the type of medical
insurance was associated with the use of these medications and
procedures.
Overall findings. In a cross-sectional evaluation of 1,404
FFS and 636 MC patients admitted to 35 U.S. hospitals with
the admission diagnosis of unstable angina, we found modestly
higher use rates of guideline-recommended medications in MC
patients. At hospital discharge, MC patients were more likely
to be discharged on aspirin or beta-blockers. Managed care
patients were also more likely to be discharged on calcium
Figure 2. Odds ratio with 95% confidence intervals of
factors associated with undergoing cardiac catheterization
during the hospitalization in 2,948 unstable angina pa-
tients in the GUARANTEE Registry. Factors associated
with a higher likelihood of undergoing angiography ap-
pear to the right of the line of identity. After adjustment
for the listed factors, fee-for-service patients were 25%
more likely to undergo cardiac catheterization.
Table 3. Hospital Outcomes in Patients With Fee-for-Service Versus
Managed Care Insurance
Managed
Care
(n 5 636)
Fee-for-
Service
(n 5 1,404) p Value
Myocardial infarction (,16 h
after admit) (%)
10 13 0.032
Additional in-hospital chest pain (%) 30 30 0.690
Recurrent infarct (%) 1 1 0.592
Stroke (%) 0.5 0.3 0.684
Death (%) 0.9 1.2 0.595
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channel blockers, the use of which is more controversial
(24,25). Although there was little difference in the use of
procedures during the hospitalization, this finding was con-
founded by the older age of the FFS patients. Thus, after
multivariate adjustment, FFS patients were 25% more likely to
undergo angiography than MC patients. This observed differ-
ence in angiography rates was probably not the result of
underuse in MC patients, as there was no difference in the
proportion of MC patients who underwent appropriate cathe-
terization according to AHCPR guidelines. In this relatively
small study with low overall mortality, there was no difference
in hospital mortality.
On the whole, these findings support the concept that
unstable angina patients with MC insurance received similar
care to FFS patients. It appears that in situations where all
patients are hospitalized, physicians do not treat patients
differently based on insurance status. Although the process of
care measures reported in this study (use of invasive cardiac
procedures, as well as the use of guideline recommended
medications) represent only a fraction of all factors that
make-up quality of care, they do represent important process
measures as they have been shown to be associated with
mortality (16,18,19,21–23).
Managed care and resource utilization. There are two
major mechanisms in which MC organizations can lower
inpatient resource utilization. The first is to decrease the rate
of hospitalization for specific conditions. This mechanism
represented the first strategy that was attempted by many MC
organizations and has on the whole been duplicated by the FFS
system (5,6). A second method for reducing resource utiliza-
tion is to decrease the number of procedures and length-of-
stay in hospitalized patients. Previous studies comparing pro-
cess of care in health maintenance organization and fee-for-
service systems have shown generally lower procedure
utilization in health maintenance organizations. Langa and
Sussman (26) found slightly higher coronary revascularization
rates in fee-for-service versus health maintenance organization
patients in California. Young and Cohen (27) showed higher
angiography and bypass surgery rates, and similar coronary
angioplasty rates in FFS systems in Massachusetts. Both of
these studies were limited by the use of administrative data-
base that may not have allowed for appropriate adjustments
for baseline differences between the cohorts, as well as rela-
tively older data (1988), that may not fully capture more recent
cost containment policies enacted in the FFS system.
In a more recent study from the Myocardial Infarction
Triage and Intervention (MITI) Registry, AMI patients admit-
ted to a single staff model health maintenance organization
had fewer procedures and similar hospital mortality in com-
parison with FFS patients (7). Compared with the present
study, the single health maintenance organization in the MITI
Registry may have had more administrative control of patient
process of care with a free-standing hospital without on-site
catheterization facilities. Although the present study may be
more generalizable than previous studies, the fact that MC and
FFS patients were admitted to the same hospitals may mini-
mize any differences in process of care measures.
Study limitations. The present study, although consistent
with previous reports, shows less dramatic differences in pro-
cess of care measures between MC and FFS patients. This
finding may be a reflection of the type of hospitals that
participated in the GUARANTEE Registry, mostly tertiary
medical centers. Previous studies have shown the strong asso-
ciation between the availability of on-site cardiac services and
greater cardiac procedure utilization (28). Because the vast
majority of hospitals that participated in the GUARANTEE
Registry had on-site catheterization facilities, this factor could
not be independently evaluated in this analysis. We also could
not control for variation in admission criteria used by the
different insurance plans. Differences in admission criteria
could bias findings by including different patient groups with
similar admission diagnoses. Another limitation of the study
was the limited information collected about the type of insur-
ance plans in the GUARANTEE Registry. Models of MC can
range from staff-model HMOs with no economic incentives to
perform procedures to contract pricing where economic incen-
tives to perform procedures may still exist. Patients classified as
having MC insurance status in this analysis, in all likelihood,
represented a wide variety of MC models. These findings
cannot be generalized to other conditions, particularly where
hospitalization is not required for treatment. Finally with such
a large number of hospitals in the Registry, we were unable to
independently evaluate the interaction between individual
hospitals and insurance type on process of care. Process of care
measures attributed to MC insurance may have simply been a
reflection of higher standards at a particular hospital indepen-
dent of insurance type.
We conclude that in patients admitted with suspected
unstable angina, MC patients are less likely to undergo coro-
nary angiography, but are more likely to be discharged on
guideline-recommended medications.
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